Reliant Pharmaceuticals

About:

Reliant Pharmaceuticals provides cardiovascular pharmaceutical products.

Website: http://www.reliantrx.com/

Top Investors: Bay City Capital, Pritzker/Vlock Family Office, BayStar Capital, Invemed Catalyst Fund

Description:

Reliant Pharmaceuticals provides cardiovascular pharmaceutical products. It is engaged in the sale and marketing of these products. Its product portfolio includes Axid, a nizatidin; InnoPran XL and DynaCirc CR for the treatment of hypertension; Omacor to reduce high triglycerides; and Rythmol SR. It provides products for the treatment of elevated cholesterol and triglycerides, acid reflux disease, and prevention of coronary complications in patients with coronary heart disease. It distributes its products to physicians engaged in primary care, cardiovascular, and specialized medical areas. Reliant Pharmaceuticals was established in 1999, headquartered in Liberty Corner, New Jersey.

Total Funding Amount:

$275M

Headquarters Location:

Bernardsville, New Jersey, United States

Founded Date:

1999-01-01

Founders:

Gary Talarico, Joseph Krivulka

Number of Employees:

501-1000

Last Funding Date:

2003-10-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai